Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYTO -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (7583)	9/28/1999 1:41:00 PM
From: BlueCrab	Respond to of 8116

Reiser seems to be following up on his CC to the letter. Some of the Yahoovians seem to think that this MAY be the signal for an AxCell spin-off; Joe reiterated his statement about the PCa "core". Somebody seems to like the idea, because it's beating a nasty-looking market. I sure do; picked up some more just before the news({>D

To: Jim Oravetz who wrote (7583)	10/1/1999 7:33:00 AM
From: Jim Oravetz	Respond to of 8116

Axcell competition in the protein research area MDS Inc. To Launch New Proteomics Business TORONTO -- MDS Inc. (MHG.A) said it is launching MDS Proteomics, a new business focused on the science of proteomics, or the large-scale study of proteins and how proteins interact in healthy and diseased cells. In a news release, the company said proteomics aids the discovery of new indicators that can be used to diagnose and treat disease. The new company will research new, more effective medicines with reduced side effects. MDS Inc. said it has several proteomics business initiatives underway, including a research collaboration with the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto, focused on protein-protein interactions for drug discovery and development, and a joint venture with MDS Protana A.S. of Denmark, which provides proteomics information to the pharmaceutical and biotechnology industries. In a separate release, MDS Inc. said it began trading Thursday under new symbols on the Toronto Stock Exchange. Its Class A common shares will now trade under the symbol "MDS.A," and its Class B non-voting shares will trade under the symbol "MDS.B." MDS Inc. is a health and life sciences company. Jim